Results 131 to 140 of about 5,328,488 (405)
Molecular Oncology, EarlyView.This study explores salivary RNA for breast cancer (BC) diagnosis, prognosis, and follow‐up. High‐throughput RNA sequencing identified distinct salivary RNA signatures, including novel transcripts, that differentiate BC from healthy controls, characterize histological and molecular subtypes, and indicate lymph node involvement.
Nicholas Rajan +9 more
wiley +1 more source
Epidemiological profile of seropositive blood donors at a tertiary care hospital in North India
CHRISMED Journal of Health and Research, 2014 Background: Transfusion-transmissible infections HIV, HBV, and HCV are among the greatest threats to blood safety for transfusion recipients. Seroprevalence among blood donors is a useful source of information on their prevalence in the community.
Jency Maria Koshy +4 more
doaj +1 more source
Should 16-Year-Olds Be Allowed to Donate Blood? A Vermont Perspective [PDF]
, 2012 Introduction: Supplying adequate blood for transfusions is an ongoing challenge for blood collection agencies. One potential source of increased Whole Blood (WB) supply is among 16-17 year-olds, whose donation rates are still quite low.
Carney, Jan +10 more
core +1 more source
Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology
Molecular Oncology, EarlyView.Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by
Jorine Arnouts +8 more
wiley +1 more source
Knowledge, Attitude and Practice on Blood Donation among Health Science Students in a University campus, South India [PDF]
, 2011 Background: The major part of demand for blood in India has been meeting through voluntary blood donations. The healthy, active and receptive huge student population is potential blood donors to meet safe blood requirements.
Binu, VS, Remya, A, Sabu, KM, Vivek, R
core
Modified screen-printed carbon electrodes application for protein tumor markers determination [PDF]
, 2009 Screen-printed carbon electrodes were modified with gold nanoparticles bound with DNA-aptamers by two different methods. Aptamers can selectively bind protein tumor markers from the blood plasma. The electrodes were tested.
Düx, M. +7 more
core +1 more source
Anemia and the Blood Donor [PDF]
Revista Brasileira de Hematologia e Hemoterapia, 2012 The World Health Organization recommends a collection rate of 10-20 whole blood units per 1000 inhabitants to address transfusion needs(1). However, demand for blood is ever-increasing as medicine continuous to develop(2). Donor selection is critical to blood transfusion safety and blood donor eligibility policies are designed to protect both the ...
openaire +4 more sources
Molecular Oncology, EarlyView.This study indicates that Merkel cell carcinoma (MCC) does not originate from Merkel cells, and identifies gene, protein & cellular expression of immune‐linked and neuroendocrine markers in primary and metastatic Merkel cell carcinoma (MCC) tumor samples, linked to Merkel cell polyomavirus (MCPyV) status, with enrichment of B‐cell and other immune cell
Richie Jeremian +10 more
wiley +1 more source
Detection of Toxoplasma gondii IgM and Cytomegalovirus IgM antibodies among blood donors in Mosul [PDF]
, 2011 Karam A. Al-Dabbagh
openalex +1 more source
Molecular Oncology, EarlyView.A comprehensive genomic and proteomic analysis of cervical cancer revealed STK11 and STX3 as a potential biomarkers of chemoradiation resistance. Our study demonstrated EGFR as a therapeutic target, paving the way for precision strategies to overcome treatment failure and the DNA repair pathway as a critical mechanism of resistance.
Janani Sambath +13 more
wiley +1 more source